Management Board meeting: 21 March 2019
Date:
21/03/2019
Location:
European Medicines Agency, Amsterdam, the Netherlands
The Management Board is an integral governance body of the Agency. It has a supervisory role with general responsibility for budgetary and planning matters, the appointment of the Executive Director and the monitoring of the Agency's performance.
-
List item
Minutes of the 103rd meeting of the Management Board: 21 March 2019 (PDF/210.88 KB)
Adopted
First published: 14/06/2019
EMA/MB/188256/2019 -
List item
Agenda for the 103rd meeting of the Management Board (PDF/126.91 KB)
Adopted
First published: 22/03/2019
EMA/MB/916015/2019 -
List item
Minor use or minor species (MUMS)/limited market scheme for veterinary medicinal products - 9th annual report (2018) (PDF/143.53 KB)
First published: 22/03/2019
EMA/713390/2018 -
List item
Decision on amending budget No 1-2019 (PDF/82.56 KB)
First published: 22/03/2019
EMA/MB/171445/20199 -
List item
Outcome of written procedures finalised during the period from 24 November 2018 to 22 February 2019 (PDF/94.02 KB)
First published: 22/03/2019
EMA/MB/112294/2019 -
List item
Rules for reimbursement of expenses for delegates attending meetings with effect from 17 March 2023 (PDF/188.7 KB)
Adopted
First published: 17/03/2017
Last updated: 22/03/2023
EMA/MB/279597/2018 Rev. 4 -
List item
Rules for the implementation of Council Regulation (EC) No 297/95 on fees payable to the European Medicines Agency and other measures - Revised implementing rules to the Fee Regulation as of 1 April 2019 (PDF/301.18 KB)
First published: 22/03/2019
EMA/MB/909612/2019 -
List item
Summary of transfers of appropriations in budget 2018 - Management Board meeting of 21 March 2019 (PDF/82.77 KB)
First published: 22/03/2019
EMA/MB/129665/2019 -
List item
2018 Annual Report on EudraVigilance for the European Parliament, the Council and the Commission - Reporting period: 1 January to 31 December 2018 (PDF/570.3 KB)
First published: 27/03/2019